Patient safety

Ramakant Vempati, Wysa cofounder and president, discusses how the startup tests its AI-backed chatbot to monitor safety and quality.

The program comes a week after the digital mental health company replaced its CEO.

Cerebral is halting prescriptions such as Adderall and Xanax for current and new patients.

The suspension comes as the digital mental health company faces increasing pressure over its prescription practices, particularly for ADHD medications.

Former vice president Matthew Truebe said he was fired after raising concerns about the company's prescribing practices, alleging Cerebral aimed to prescribe stimulants to all its ADHD patients to increase retention.

It features a remote patient monitoring system that allows doctors to track multiple patients in a single dashboard.

The IntelliVue MX750 and MX850 patient monitors received an EUA last year and a European CE mark in 2019.

The prescription app uses a smartphone or smart speaker to measure breathing.

Also, AICS unveils its latest AI-powered medical solutions, including a hospital information system, drug safety system, and an EMR search platform.

The funding round comes months after the company raised $19.5 million in Series A financing.